A Lafuma

3.1k total citations
131 papers, 2.4k citations indexed

About

A Lafuma is a scholar working on Ophthalmology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A Lafuma has authored 131 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Ophthalmology, 28 papers in Epidemiology and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A Lafuma's work include Glaucoma and retinal disorders (21 papers), Corneal surgery and disorders (17 papers) and Retinal Diseases and Treatments (15 papers). A Lafuma is often cited by papers focused on Glaucoma and retinal disorders (21 papers), Corneal surgery and disorders (17 papers) and Retinal Diseases and Treatments (15 papers). A Lafuma collaborates with scholars based in France, United Kingdom and Italy. A Lafuma's co-authors include G Berdeaux, Francis Fagnani, Babak Khoshnood, K Hieke, Guy J. Ben Simon, Mounir Mesbah, Antoine P. Brézin, Philippe Bastide, Viviane Jeanbat and Béatrice Cochener and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Journal of Hepatology.

In The Last Decade

A Lafuma

126 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Lafuma France 25 894 585 527 413 256 131 2.4k
Elham Hatef United States 26 848 0.9× 389 0.7× 242 0.5× 104 0.3× 313 1.2× 70 1.9k
S. Bouée France 23 239 0.3× 127 0.2× 641 1.2× 269 0.7× 162 0.6× 96 1.7k
G. Chodick Israel 18 144 0.2× 335 0.6× 292 0.6× 178 0.4× 115 0.4× 52 1.5k
Richard Contreras United States 27 145 0.2× 199 0.3× 502 1.0× 932 2.3× 299 1.2× 72 3.4k
Robin J. Larson United States 20 120 0.1× 102 0.2× 589 1.1× 425 1.0× 155 0.6× 29 2.2k
Piergiorgio Duca Italy 27 141 0.2× 328 0.6× 1.1k 2.1× 882 2.1× 180 0.7× 99 2.9k
Michael B. Shapiro United States 37 239 0.3× 331 0.6× 568 1.1× 1.5k 3.6× 345 1.3× 108 3.9k
Daniel C. Perry United Kingdom 28 191 0.2× 187 0.3× 346 0.7× 1.5k 3.6× 257 1.0× 157 2.4k
Fabio Cardinale Italy 27 107 0.1× 138 0.2× 454 0.9× 319 0.8× 275 1.1× 117 3.0k
Domenica Matranga Italy 26 87 0.1× 340 0.6× 598 1.1× 409 1.0× 121 0.5× 124 2.1k

Countries citing papers authored by A Lafuma

Since Specialization
Citations

This map shows the geographic impact of A Lafuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Lafuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Lafuma more than expected).

Fields of papers citing papers by A Lafuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Lafuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Lafuma. The network helps show where A Lafuma may publish in the future.

Co-authorship network of co-authors of A Lafuma

This figure shows the co-authorship network connecting the top 25 collaborators of A Lafuma. A scholar is included among the top collaborators of A Lafuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Lafuma. A Lafuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dohollou, Nadine, et al.. (2016). French Prospective Multi-Center Cohort on The Decision Impact Assessment. Value in Health. 19(3). A297–A297. 2 indexed citations
2.
Benhamou, Dan, Vincent Piriou, Pierre Albaladéjo, et al.. (2016). Ready-to-use pre-filled syringes of atropine for anaesthesia care in French hospitals – a budget impact analysis. Anaesthesia Critical Care & Pain Medicine. 36(2). 115–121. 13 indexed citations
3.
Thiébaut, Anne, et al.. (2014). Allogeneic Stem Cell Transplant With Graft Versus Host Disease In France In 2012 Based On National Hospital Databases (Pmsi). Value in Health. 17(7). A524–A524. 1 indexed citations
4.
Ducasse, Aurélie, et al.. (2013). Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof® SN60WF, Akreos® AO-MI60 and Hoya® YA-60BB. Journal Français d Ophtalmologie. 36(7). 575–582. 4 indexed citations
5.
Lafuma, A, J. Robert, & G Berdeaux. (2011). PSS1 Ocular Discomfort, Compliance and Intra-Ocular Pressure (Iop) Control in Patients Treated for Glaucoma. Value in Health. 14(7). A502–A502. 1 indexed citations
6.
Gauthier, Laurent, et al.. (2010). Neodymium:YAG laser rates after bilateral implantation of hydrophobic or hydrophilic multifocal intraocular lenses: Twenty-four month retrospective comparative study. Journal of Cataract & Refractive Surgery. 36(7). 1195–1200. 21 indexed citations
7.
Michallet, Mauricette, Jean‐Pierre Gangneux, A Lafuma, et al.. (2010). Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system. Journal of Medical Economics. 14(1). 28–35. 19 indexed citations
8.
Boureau, C, A Lafuma, Viviane Jeanbat, Andrew F Smith, & G Berdeaux. (2009). Cost of cataract surgery after implantation of three intraocular lenses. SHILAP Revista de lepidopterología. 5 indexed citations
9.
Lafuma, A, et al.. (2009). Modelling lifetime cost consequences of toric compared with standard IOLs in cataract surgery of astigmatic patients in four European countries. Journal of Medical Economics. 12(3). 230–237. 23 indexed citations
10.
Boureau, C, A Lafuma, Viviane Jeanbat, G Berdeaux, & Andrew F. Smith. (2009). Incidence of Nd:YAG laser capsulotomies after cataract surgery: comparison of 3 square-edged lenses of different composition. Canadian Journal of Ophthalmology. 44(2). 165–170. 16 indexed citations
11.
Tacconelli, Evelina, G Smith, K Hieke, A Lafuma, & Philippe Bastide. (2009). Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. Journal of Hospital Infection. 72(2). 97–103. 108 indexed citations
12.
Lafuma, A & G Berdeaux. (2008). Modelling lifetime cost consequences of ReSTOR®in cataract surgery in four European countries. BMC Ophthalmology. 8(1). 12–12. 15 indexed citations
13.
Douillard, Jean‐Yves, P. Tilleul, Marc Ychou, et al.. (2007). Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting. Oncology. 72(3-4). 248–254. 18 indexed citations
14.
Bouée, S., A Lafuma, Francis Fagnani, Pierre J. Meunier, & Jean‐Yves Reginster. (2005). Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in six European countries. Open Repository and Bibliography (University of Liège).
15.
Brézin, Antoine P., A Lafuma, Francis Fagnani, Mounir Mesbah, & G Berdeaux. (2005). Prevalence and burden of self-reported blindness and low vision for individuals living in institutions: a nationwide survey. Health and Quality of Life Outcomes. 3(1). 27–27. 20 indexed citations
16.
Lafuma, A, Joseph Monsonégo, M. Moyal‐Barracco, & C. Pribil. (2004). [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].. PubMed. 130(8-9 Pt 1). 731–6. 10 indexed citations
17.
Denis, Philippe, A Lafuma, & G Berdeaux. (2004). Medical Predictive Factors of Glaucoma Treatment Costs. Journal of Glaucoma. 13(4). 283–290. 33 indexed citations
18.
Denis, Philippe, A Lafuma, & G Berdeaux. (2004). Medical Outcomes of Glaucoma Therapy from a Nationwide Representative Survey. Clinical Drug Investigation. 24(6). 343–352. 18 indexed citations
19.
Lafuma, A, et al.. (2000). [Clinico-economic assessment of milnacipran in the prevention of depressive episodes].. PubMed. 25(5). 401–7. 2 indexed citations
20.
Berdeaux, G, et al.. (1998). Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults. PharmacoEconomics. 14(3). 313–322. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elham Hatef Breakdown of academic impact, for papers by S. Bouée Breakdown of academic impact, for papers by G. Chodick Breakdown of academic impact, for papers by Richard Contreras Breakdown of academic impact, for papers by Robin J. Larson Breakdown of academic impact, for papers by Piergiorgio Duca Breakdown of academic impact, for papers by Michael B. Shapiro Breakdown of academic impact, for papers by Daniel C. Perry Breakdown of academic impact, for papers by Fabio Cardinale Breakdown of academic impact, for papers by Domenica Matranga
Rankless by CCL
2026